Patents for A61P 35 - Antineoplastic agents (221,099)
10/2005
10/12/2005EP1583536A2 Method of treatment of prostate cancer and composition for treatment thereof
10/12/2005EP1583524A1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer
10/12/2005EP1583523A1 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments
10/12/2005EP1583522A1 Use of cyclin d1 inhibitors
10/12/2005EP1583521A1 Use of hypericin and/or the derivatives thereof for the prevention of primary tumours
10/12/2005EP1583503A2 Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
10/12/2005EP1583502A2 Methods and reagents for the enhancement of virus transduction in the bladder epithelium
10/12/2005EP1385837B1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors
10/12/2005EP1359943B1 Biotin-derivates and their conjugates with chelating agents
10/12/2005EP1309579B1 Inhibitors of matrix metalloproteinases
10/12/2005EP1294918B1 Replication deficient adenoviral tnf vector
10/12/2005EP1272195B1 Use of fulvestrant in the treatment of resistant breast cancer
10/12/2005EP1242408B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1185249B1 Use of a biodegradable polymer
10/12/2005EP1169322B1 Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6
10/12/2005EP1163219B1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
10/12/2005EP1150982B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkB-alpha
10/12/2005EP1143949B1 19-nor-vitamin d3 compounds with calcemic activity
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives
10/12/2005EP0794774B1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
10/12/2005CN1682111A Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy
10/12/2005CN1681833A Sir2 products and activities
10/12/2005CN1681824A A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681817A Biologically active compounds
10/12/2005CN1681816A Novel pyrazolopyridines as cyclin dependent kinase inhibitors
10/12/2005CN1681813A Synthesis of indolizines
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681810A Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681809A Novel isothiazole and isoxazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681806A Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic
10/12/2005CN1681805A Novel imidazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681558A Platinum complexes as antitumor agents in combination with biochemical modulation
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681528A Use of urease for inhibiting cancer cell growth
10/12/2005CN1681515A Combination therapy comprising a bisphosphonate and a HMG-COA reductase inhibitor
10/12/2005CN1681513A Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
10/12/2005CN1681511A Combinations of drugs for the treatment of neoplasms
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681505A Combination of a) N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia
10/12/2005CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE)
10/12/2005CN1681502A Novel triazole compounds as transforming growth factors (TGF) inhibitors
10/12/2005CN1681501A Novel pyrazole compounds as transforming growth factor (TGF) inhibitors
10/12/2005CN1681495A Combination therapy for hyperplasia diseases
10/12/2005CN1681489A Combination of chemotherapeutic drugs for increasing antitumor activity
10/12/2005CN1680438A Human pifl gene, its coding protein and use thereof
10/12/2005CN1680431A Crystal of human avidin protein and preparation thereof
10/12/2005CN1680424A Preparation and use for active saponin
10/12/2005CN1680410A Platinum(II) complex with alkoxy carboxylic acid as ligand and antineoplastic characteristic
10/12/2005CN1680409A Diphospho-acid complex of radiative technetium-99m marked oxazole phosphinic acid
10/12/2005CN1680402A Water soluble prodrugs of hindered alcohols
10/12/2005CN1680390A Halogenated dihydroartemisine, preparation and use thereof
10/12/2005CN1680384A Norcantharidin platinum complex and its use
10/12/2005CN1680379A 2-pyridinyl-6, 7, 8, 9-tetrahydropyrimido{1, 2-a}pyrimidin-4-one and 7-pyridinyl-1, 3-dihydoimidazo{1, 2-a}pyrimidin-5(1h)one derivatives
10/12/2005CN1680378A Pyrazolo(4, 3-d)pyrimidine derivatives
10/12/2005CN1680372A New benzo[b]chromeno-naphthyridin-7-one and pyrano[2', 3':7, 8] quino[2, 3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
10/12/2005CN1680370A Epothilones C, and its preparation and use as cell inhibitor
10/12/2005CN1680367A Substituted 2-(2, 6-dioxopiperidin-3-yp)-phthalimides and 1-oxoisoindolines and method for reducing TNF alpha levels
10/12/2005CN1680358A Composition concerned with isoflavone and the similar and therapeutical method
10/12/2005CN1680353A Rice bean flavone extracts and their use
10/12/2005CN1680336A New imidazole derivative, method for producing the same and use of the same
10/12/2005CN1680334A Fused pyrazolyls
10/12/2005CN1680333A Anti-virus pyrazole derivatives
10/12/2005CN1680313A Farnesyl transferase inhibitors
10/12/2005CN1680304A Lingshui alcohol with anti-cancer activity, its preparation and use
10/12/2005CN1680284A New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/12/2005CN1680270A 3, 4, 5,-substituted benzyl ethylene derivatives and their preparation and use
10/12/2005CN1680252A C60 trans-succinate with biologic activity and its synthesis
10/12/2005CN1680248A Use of 2', 4'-dihydroxy-6'-methoxy-3', 5'-dimethyl chalkone as reversing agent for resistance of multiple tumours drugs
10/12/2005CN1679970A Preparation of radiative immune guiding operating medicine of colorectal disease
10/12/2005CN1679964A Antisense nucleic acid medicine composition with bcr3/abl2 and VEGF gene function inhibition and use thereof
10/12/2005CN1679952A Anticarcinogenic medicine composition
10/12/2005CN1679951A Medicinal composition for tumor body
10/12/2005CN1679950A Anticarcinogenic internal implant agent
10/12/2005CN1679949A Anticarcinogenic internal implant agent
10/12/2005CN1679948A Anticarcinogenic internal implant agent
10/12/2005CN1679947A Anticarcinogen composition
10/12/2005CN1679946A Anticarcinogen composition
10/12/2005CN1679945A Anticarcinogen composition
10/12/2005CN1679944A Anticarcinogen composition
10/12/2005CN1679938A Pharmaceutical compositions
10/12/2005CN1679937A Compositions and methods for treating or preventing inflammatory diseases
10/12/2005CN1679936A Anticarcinogen composition
10/12/2005CN1679934A Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
10/12/2005CN1679932A Ordered molecular presentation of antigens, method of preparation and use
10/12/2005CN1679930A Human papilloma virus and heat shock protein recombinant protein vaccine and use thereof
10/12/2005CN1679919A Intracellular isoform of the interleukin-1 receptor antagonist
10/12/2005CN1679915A Peptide antagonists of zonulin and methods for use of the same
10/12/2005CN1679912A Extraction of liuwei Dihuang polysaccharide, products and use thereof
10/12/2005CN1679911A Process for producing a culture of antrodia camphorata and product obtained thereby
10/12/2005CN1679908A Chinese medicine for treating tumor and preparation thereof
10/12/2005CN1679899A Chinese medicine capsules for treating primary hepatocarcinoma and preparation thereof
10/12/2005CN1679898A Chinese medicine composition for treating hepatitis and cancers
10/12/2005CN1679892A Oral liquid for treating cancer and preparation thereof
10/12/2005CN1679889A Medicine for inhibiting and eliminating cancer
10/12/2005CN1679883A Compound light-yellow sophora root freeze-drying injection and preparation thereof